
July 2020
SAFETY OBSERVER N169
22 PAGES
COVID-19 Guidance
New CIOMS DILI Guidance
FDA updates E2B Guidance
FDA updates REMS Guidance
EU PV Training Material
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
SAFETY OBSERVER N169
22 PAGES
COVID-19 Guidance
New CIOMS DILI Guidance
FDA updates E2B Guidance
FDA updates REMS Guidance
EU PV Training Material
Draft GVP Module XVI on RMMs
EMA CTIS Training
Post-Brexit Guidance
Canada ADR Reporting guidance
And more...
EU Clinical Trial Regulation
New FDA Draft Guidance
PV in the COVID-19 era
Product Safety News
Number of users
Number of users